LOCAL 409-203-5030
TOLL FREE 888-588-1695

Provost Umphrey Law Firm LLP

Hard-Working Lawyers for Hard-Working People

Testosterone Litigation Picks Up Speed

In February 2014, the U.S. Food and Drug Administration (FDA) announced they were launching an investigation into the link between testosterone and an increased risk of cardiovascular injuries. The FDA was prompted to perform this investigation after the Journal of the American Medical Association (JAMA) released a study that linked Androgel and other testosterone treatments to an increased risk of heart attack, stroke and even death.

The number of prescriptions written for "Low-T" testosterone therapy has exploded in recent years, from about 1 million in the year 2000 to nearly 5.5 million in 2011. The JAMA study showed that 25% of the men who received prescriptions had never even had their testosterone levels tested, and only about half the men who were tested actually had abnormally low testosterone levels, a condition called hypogonadism.

Effective advertising of "Low-T" supplements on television, radio and the Internet has helped drug companies convince men to use these supplements. It is clear that anyone who has suffered a heart attack, stroke, blood clots, liver damage or other health complications after taking testosterone should consult with an attorney to discuss a potential claim. To contact Provost*Umphrey about a potential Testosterone claim, please visit www.provostumphrey.com/Pharmaceutical-Litigation/Testosterone or call 1-800-289-0101.

In addition to reviewing potential Testosterone cases, Provost*Umphrey is actively reviewing cases involving a number of other medical and pharmaceutical products including the following:

  1. Transvaginal Mesh (TVM) - Transvaginal Meshes are devices implanted to help women who suffer from pelvic organ prolapse and stress urinary incontinence, both common problems particularly for women who have had children. Unfortunately, the meshes cause unwanted abdominal adhesions, erosions, and pain. Tens of thousands of women are affected.
  2. Xarelto - Xarelto is a relatively new anticoagulant originally designed to replace Coumadin. While Xarelto does not require the same frequent testing to monitor dosage Coumadin does, it carries the serious danger of not being reversible. If a patient's levels become too high, there is a serious risk of hemorrhaging and uncontrolled bleeding that can even result in death.
  3. Granuflo - Granuflo is a chemical used in the dialysis process. It was removed from the market after it was linked to cardiac arrests due to elevated bicarbonate levels in the blood.
  4. Mirena - The Mirena device has a known propensity to migrate and perforate the uterus even ending up in nearby organs in some cases.

Call Provost*Umphrey at 1-800-289-0101 if you have a TVM, Xarelto, Granuflo, Mirena, or other pharmaceutical or medical device case you would like us to review.